Filed: 8/6/2024ACC: 0001104659-24-086285
📋 What this filing means
WUXI APPTEC CO., LTD. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $23.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$23.33M
Total AUM (reported)
11.67M
Total Shares
Allocation by class
ADS$12.19M52.3%
COM$11.14M47.7%
Portfolio Concentration
Top 3$23.33M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.67M
Sole
Full voting authority
11.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ADAGENE INC
SOLEShares3.98M
TypeSH
Market value$12.19M
52.26%
Sole
3.98M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares7.68M
TypeSH
Market value$11.14M
47.74%
Sole
7.68M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ADAGENE INCSOLE | ADS | 3.98M | SH | $12.19M 52.26% | 3.98M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM | 7.68M | SH | $11.14M 47.74% | 7.68M | 0.00 | 0.00 |